Amyris: Delay To Key Strategic Transaction; May Run Out Of Funds (NASDAQ:AMRS)
Amyris announces delay to key strategic transaction allegedly due to antitrust review requirements. Click here to see why I consider AMRS stock an avoid now.
Source: seekingalpha.com